Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bradley Martin

Concepts (384)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
43
2026
601
8.430
Why?
Chronic Pain
17
2024
189
5.620
Why?
Opioid-Related Disorders
17
2024
404
3.950
Why?
Drug Overdose
10
2022
161
3.560
Why?
Drug Prescriptions
16
2026
112
3.410
Why?
Medicaid
23
2021
264
2.660
Why?
Alcoholism
4
2022
236
2.330
Why?
Tramadol
3
2024
30
2.320
Why?
Antipsychotic Agents
10
2018
234
1.890
Why?
Retrospective Studies
47
2026
6694
1.880
Why?
Asthma
5
2025
313
1.880
Why?
Adult
59
2026
14205
1.680
Why?
Anticoagulants
7
2025
276
1.670
Why?
United States
54
2025
5215
1.650
Why?
Humans
115
2026
52441
1.610
Why?
Middle Aged
58
2025
13133
1.550
Why?
Osteoarthritis, Knee
3
2017
97
1.440
Why?
Adrenal Cortex Hormones
3
2025
116
1.430
Why?
Pain
11
2022
373
1.420
Why?
Female
77
2026
28277
1.390
Why?
Young Adult
29
2026
4346
1.320
Why?
Health Care Costs
10
2022
176
1.310
Why?
Aged
46
2025
10242
1.310
Why?
Male
72
2025
26874
1.290
Why?
Adolescent
38
2025
6713
1.280
Why?
Atrial Fibrillation
4
2016
196
1.210
Why?
Viscosupplements
3
2017
14
1.200
Why?
Venous Thromboembolism
3
2025
80
1.180
Why?
Hyaluronic Acid
3
2017
38
1.170
Why?
Mental Disorders
7
2025
427
1.150
Why?
Medication Adherence
6
2016
133
1.120
Why?
Emergency Service, Hospital
6
2016
521
1.100
Why?
Hypoglycemic Agents
2
2025
223
1.060
Why?
Schizophrenia
5
2009
257
1.060
Why?
Cohort Studies
17
2024
1576
1.020
Why?
Arthroplasty, Replacement, Knee
4
2017
288
1.020
Why?
Analgesics, Non-Narcotic
3
2012
118
1.000
Why?
Acetaminophen
4
2015
272
0.990
Why?
Substance-Related Disorders
5
2021
615
0.980
Why?
Warfarin
4
2016
81
0.960
Why?
Patient Compliance
6
2009
228
0.950
Why?
Veterans
10
2024
573
0.920
Why?
Psychotropic Drugs
1
2025
76
0.870
Why?
Metformin
1
2025
82
0.860
Why?
Psychotherapy
1
2025
112
0.840
Why?
Suicide
1
2025
85
0.830
Why?
Prescription Drugs
6
2014
40
0.820
Why?
Cost-Benefit Analysis
5
2020
271
0.810
Why?
Diabetes Mellitus, Type 2
2
2025
570
0.790
Why?
Insurance, Health
7
2020
132
0.780
Why?
Attention Deficit Disorder with Hyperactivity
1
2023
177
0.740
Why?
Arkansas
14
2026
2013
0.730
Why?
Neck Pain
2
2021
10
0.730
Why?
Back Pain
2
2021
39
0.720
Why?
Central Nervous System Stimulants
1
2023
198
0.720
Why?
Drug Utilization
11
2017
77
0.710
Why?
Hospitalization
6
2016
731
0.700
Why?
Arthralgia
1
2021
44
0.690
Why?
Professional-Patient Relations
1
2021
46
0.690
Why?
Insurance, Pharmaceutical Services
2
2019
25
0.680
Why?
Stroke
3
2016
527
0.680
Why?
Decision Support Techniques
3
2016
73
0.670
Why?
Risk Factors
15
2025
3971
0.670
Why?
Databases, Factual
12
2026
721
0.650
Why?
Logistic Models
8
2016
930
0.650
Why?
Narcotic Antagonists
2
2024
150
0.630
Why?
Breast Neoplasms
4
2023
1203
0.620
Why?
Naloxone
1
2020
85
0.610
Why?
Hydrocodone
3
2024
20
0.600
Why?
Oxycodone
3
2024
26
0.600
Why?
Legislation, Drug
1
2019
17
0.590
Why?
Contraception
1
2019
31
0.580
Why?
Proton Pump Inhibitors
2
2016
94
0.580
Why?
Follow-Up Studies
8
2024
2294
0.540
Why?
Guidelines as Topic
1
2018
111
0.540
Why?
Mammography
1
2018
97
0.540
Why?
Buprenorphine
3
2024
155
0.530
Why?
Practice Guidelines as Topic
3
2017
498
0.530
Why?
Propensity Score
4
2025
160
0.520
Why?
Histamine H2 Antagonists
1
2016
28
0.510
Why?
Peptic Ulcer
1
2016
15
0.510
Why?
Purinergic P2Y Receptor Antagonists
3
2022
34
0.490
Why?
Pyridones
1
2016
35
0.490
Why?
Education, Pharmacy, Graduate
1
2016
20
0.490
Why?
Time Factors
10
2025
2987
0.480
Why?
Risk
4
2020
315
0.480
Why?
Aged, 80 and over
15
2025
3449
0.480
Why?
Inappropriate Prescribing
1
2016
24
0.470
Why?
Safety-Based Drug Withdrawals
1
2015
7
0.470
Why?
Dextropropoxyphene
1
2015
6
0.470
Why?
Insurance Claim Review
5
2010
41
0.470
Why?
Health Expenditures
3
2011
74
0.470
Why?
Tobacco Use Cessation
1
2015
10
0.470
Why?
For-Profit Insurance Plans
1
2015
2
0.470
Why?
Brain Ischemia
2
2016
168
0.460
Why?
Pyrazoles
1
2016
116
0.450
Why?
Mass Screening
1
2018
354
0.450
Why?
Quinolines
1
2015
44
0.450
Why?
Acetates
1
2015
51
0.440
Why?
Stress, Psychological
1
2016
275
0.440
Why?
Diabetic Neuropathies
1
2015
57
0.440
Why?
Opiate Substitution Treatment
3
2024
107
0.440
Why?
Anticonvulsants
2
2006
136
0.440
Why?
Insurance Claim Reporting
2
2011
11
0.430
Why?
Low Back Pain
2
2025
31
0.430
Why?
Critical Illness
1
2016
306
0.430
Why?
Curriculum
2
2018
406
0.420
Why?
Palliative Care
1
2016
194
0.420
Why?
Tobacco Products
1
2015
126
0.410
Why?
Pain Management
1
2015
187
0.410
Why?
Neoplasms
1
2023
1314
0.400
Why?
Postoperative Complications
3
2025
1065
0.400
Why?
Injections, Intra-Articular
3
2017
38
0.400
Why?
Computers, Handheld
1
2013
23
0.390
Why?
Evidence-Based Medicine
3
2014
271
0.390
Why?
United States Department of Veterans Affairs
5
2024
291
0.380
Why?
Medicare
7
2025
281
0.380
Why?
Age Factors
6
2018
1120
0.380
Why?
Carcinoma, Non-Small-Cell Lung
2
2025
177
0.370
Why?
Quality-Adjusted Life Years
3
2020
67
0.370
Why?
Neuralgia
2
2023
68
0.370
Why?
Cross-Sectional Studies
6
2022
1677
0.370
Why?
Child
11
2025
7194
0.360
Why?
Health Knowledge, Attitudes, Practice
1
2015
504
0.350
Why?
Case-Control Studies
7
2023
1202
0.350
Why?
Brain Neoplasms
2
2025
302
0.340
Why?
Community Pharmacy Services
3
2020
71
0.330
Why?
Health Personnel
1
2013
255
0.320
Why?
Kidney Failure, Chronic
2
2022
205
0.320
Why?
Employment
2
2015
94
0.310
Why?
Age Distribution
5
2018
176
0.300
Why?
Antidepressive Agents
2
2009
176
0.300
Why?
Motor Vehicles
1
2009
14
0.300
Why?
Automobile Driving
1
2009
27
0.300
Why?
Medication Errors
1
2009
24
0.300
Why?
Pharmacists
3
2019
150
0.290
Why?
Prevalence
5
2018
1016
0.280
Why?
Hemorrhage
3
2023
225
0.280
Why?
Cost of Illness
3
2013
120
0.280
Why?
Lung Neoplasms
2
2025
643
0.280
Why?
Physicians, Primary Care
2
2018
43
0.280
Why?
Pain Measurement
6
2021
263
0.280
Why?
Health Resources
2
2012
71
0.270
Why?
College Admission Test
2
2018
13
0.270
Why?
Antimanic Agents
1
2007
14
0.270
Why?
School Admission Criteria
2
2018
34
0.260
Why?
Schools, Pharmacy
2
2018
56
0.260
Why?
Markov Chains
2
2020
29
0.260
Why?
Pharmaceutical Services
2
2018
52
0.260
Why?
Georgia
6
2006
41
0.260
Why?
Orthopedic Procedures
2
2017
70
0.250
Why?
Constipation
1
2006
38
0.250
Why?
Overweight
1
2009
230
0.250
Why?
Multivariate Analysis
4
2017
601
0.250
Why?
Least-Squares Analysis
4
2011
44
0.250
Why?
Longitudinal Studies
3
2026
756
0.240
Why?
United States Food and Drug Administration
4
2011
89
0.240
Why?
Knee Joint
2
2017
165
0.240
Why?
Pancreaticoduodenectomy
1
2025
13
0.240
Why?
Platelet Aggregation Inhibitors
2
2021
211
0.240
Why?
Pancreatectomy
1
2025
18
0.240
Why?
Hepatectomy
1
2025
25
0.240
Why?
Cranial Irradiation
1
2025
24
0.230
Why?
Odds Ratio
4
2020
563
0.230
Why?
Students, Pharmacy
2
2018
130
0.230
Why?
Risperidone
2
2010
25
0.220
Why?
Colectomy
1
2025
35
0.220
Why?
North Carolina
5
2011
55
0.220
Why?
Polypharmacy
1
2004
15
0.220
Why?
Drug Costs
2
2020
40
0.220
Why?
Blood Glucose
2
2025
483
0.210
Why?
Cross-Over Studies
1
2025
236
0.210
Why?
Pregnancy Outcome
1
2026
255
0.210
Why?
General Practitioners
1
2023
4
0.210
Why?
Severity of Illness Index
3
2017
1045
0.210
Why?
Patient Selection
1
2025
269
0.210
Why?
Haloperidol
1
2003
46
0.200
Why?
Renal Dialysis
2
2022
189
0.200
Why?
Pancreatic Neoplasms
1
2025
208
0.200
Why?
Motivation
1
2025
283
0.200
Why?
Direct Service Costs
1
2003
4
0.200
Why?
Controlled Substances
1
2022
5
0.200
Why?
Irritable Bowel Syndrome
1
2003
17
0.200
Why?
Aftercare
1
2023
67
0.200
Why?
Dose-Response Relationship, Drug
5
2014
1365
0.190
Why?
Premedication
1
2002
18
0.190
Why?
Health Services Needs and Demand
1
2004
161
0.190
Why?
Common Cold
1
2002
5
0.180
Why?
Bronchitis
1
2002
9
0.180
Why?
Thromboembolism
1
2002
48
0.180
Why?
Advisory Committees
3
2018
74
0.180
Why?
Proportional Hazards Models
4
2017
446
0.180
Why?
Liver Neoplasms
1
2025
341
0.180
Why?
Accidents
1
2021
19
0.180
Why?
Respiratory Insufficiency
1
2023
114
0.180
Why?
Prescription Drug Misuse
2
2018
31
0.180
Why?
Colorectal Neoplasms
1
2025
286
0.180
Why?
Depressive Disorder, Major
2
2020
148
0.180
Why?
Pregnancy Complications
1
2026
399
0.180
Why?
Forecasting
3
2009
151
0.180
Why?
Ambulatory Care Facilities
1
2002
122
0.170
Why?
Mental Health Services
1
2004
207
0.170
Why?
Respiratory Tract Infections
1
2002
82
0.170
Why?
Patient Discharge
1
2023
320
0.170
Why?
Delivery of Health Care
2
2021
317
0.170
Why?
Interprofessional Relations
2
2018
91
0.170
Why?
Afghan Campaign 2001-
2
2018
39
0.170
Why?
Regression Analysis
5
2013
400
0.170
Why?
Obesity
1
2009
1176
0.160
Why?
Administration, Oral
2
2016
455
0.160
Why?
Decision Making
5
2018
273
0.160
Why?
Administration, Intranasal
1
2020
30
0.160
Why?
Cardiovascular Diseases
2
2018
493
0.160
Why?
Economics, Pharmaceutical
2
2009
6
0.160
Why?
Selection Bias
2
2009
15
0.160
Why?
Treatment Outcome
8
2025
5508
0.160
Why?
Social Media
1
2022
120
0.160
Why?
Comparative Effectiveness Research
2
2009
51
0.150
Why?
Preventive Health Services
1
2020
53
0.150
Why?
Benzodiazepines
2
2018
71
0.150
Why?
Child, Preschool
5
2011
4046
0.150
Why?
Insurance Coverage
1
2020
106
0.150
Why?
Drug Administration Schedule
3
2011
370
0.150
Why?
Coronary Restenosis
1
2019
39
0.150
Why?
Guideline Adherence
3
2025
142
0.150
Why?
Sepsis
1
2021
236
0.150
Why?
Pregnancy
1
2026
2642
0.150
Why?
Health Care Surveys
2
2011
177
0.140
Why?
Infant, Newborn
1
2026
2871
0.140
Why?
Public Health Surveillance
1
2018
18
0.140
Why?
Thiazoles
2
2016
53
0.140
Why?
Sleep Deprivation
1
2018
18
0.140
Why?
Papillomavirus Vaccines
1
2019
69
0.140
Why?
Pharmacies
1
2019
61
0.140
Why?
Physicians
1
2021
237
0.140
Why?
Risk Assessment
3
2025
1349
0.140
Why?
Chronic Disease
5
2011
579
0.140
Why?
Metabolic Diseases
1
2018
48
0.130
Why?
Veterans Health
2
2014
61
0.130
Why?
Molecular Weight
1
2017
78
0.130
Why?
Acute Pain
1
2017
12
0.130
Why?
Coronary Vessels
1
2019
169
0.130
Why?
Papillomavirus Infections
1
2019
170
0.130
Why?
Coronary Angiography
1
2019
367
0.130
Why?
Fractional Flow Reserve, Myocardial
1
2019
127
0.130
Why?
Educational Measurement
1
2018
196
0.130
Why?
Eosinophils
1
2017
39
0.130
Why?
Monte Carlo Method
1
2016
89
0.130
Why?
Early Detection of Cancer
1
2018
185
0.120
Why?
Chilaiditi Syndrome
1
2015
1
0.120
Why?
Education, Pharmacy
1
2018
156
0.120
Why?
Anti-Bacterial Agents
1
2002
816
0.120
Why?
Incidental Findings
1
2015
43
0.120
Why?
Geriatrics
1
2016
41
0.120
Why?
India
1
2015
60
0.120
Why?
Health Services Accessibility
1
2020
444
0.120
Why?
Sex Distribution
1
2015
138
0.110
Why?
Health Policy
3
2011
162
0.110
Why?
Models, Theoretical
1
2016
181
0.110
Why?
Sulfides
1
2015
29
0.110
Why?
Cyclopropanes
1
2015
27
0.110
Why?
Thrombosis
1
2018
250
0.110
Why?
Pyridines
1
2016
137
0.110
Why?
Income
1
2015
106
0.110
Why?
Renal Insufficiency, Chronic
1
2018
198
0.110
Why?
Anti-Asthmatic Agents
1
2015
33
0.110
Why?
Coronary Artery Disease
1
2019
323
0.110
Why?
Societies, Medical
1
2016
200
0.110
Why?
Sarcopenia
1
2015
99
0.110
Why?
Self Report
1
2016
221
0.110
Why?
Long-Term Care
3
2012
50
0.110
Why?
Educational Status
1
2015
227
0.110
Why?
SEER Program
2
2025
105
0.110
Why?
Disease Progression
1
2017
870
0.100
Why?
Enoxaparin
2
2025
31
0.100
Why?
California
2
2004
92
0.100
Why?
Comorbidity
5
2017
637
0.100
Why?
Health Literacy
1
2015
131
0.100
Why?
Health Behavior
1
2015
256
0.100
Why?
Monitoring, Physiologic
1
2013
122
0.100
Why?
Prescriptions
2
2011
11
0.100
Why?
Sensitivity and Specificity
1
2015
871
0.100
Why?
Infant
3
2011
3709
0.090
Why?
Drug Therapy, Combination
2
2004
404
0.090
Why?
Managed Care Programs
1
2012
36
0.090
Why?
Ticlopidine
1
2012
71
0.090
Why?
Predictive Value of Tests
2
2019
938
0.090
Why?
Randomized Controlled Trials as Topic
2
2025
625
0.090
Why?
Deductibles and Coinsurance
1
2011
2
0.090
Why?
Hypertension, Pulmonary
1
2012
102
0.080
Why?
Incidence
3
2025
1096
0.080
Why?
Body Mass Index
2
2013
701
0.080
Why?
Calibration
1
2009
56
0.080
Why?
International Classification of Diseases
1
2009
70
0.080
Why?
Clozapine
2
2010
25
0.080
Why?
Analysis of Variance
1
2010
558
0.070
Why?
Reference Values
1
2009
316
0.070
Why?
Treatment Refusal
1
2009
35
0.070
Why?
Carbamazepine
1
2007
13
0.070
Why?
Lithium Compounds
1
2007
12
0.070
Why?
Mental Health
1
2010
237
0.070
Why?
Alendronate
1
2007
24
0.070
Why?
Fractures, Spontaneous
1
2007
15
0.070
Why?
Valproic Acid
1
2007
35
0.070
Why?
Internationality
3
2014
46
0.070
Why?
Chemotherapy, Adjuvant
1
2007
122
0.060
Why?
Osteoporosis, Postmenopausal
1
2007
30
0.060
Why?
Affect
1
2007
107
0.060
Why?
Drug Labeling
1
2006
11
0.060
Why?
Bone Density Conservation Agents
1
2007
75
0.060
Why?
Data Collection
2
2009
285
0.060
Why?
Adrenergic beta-Agonists
1
2005
39
0.060
Why?
Self Disclosure
1
2005
13
0.060
Why?
Australia
1
2025
97
0.060
Why?
Multicenter Studies as Topic
1
2025
112
0.060
Why?
Drug Interactions
2
2018
198
0.060
Why?
Depression
1
2009
603
0.050
Why?
Factor Analysis, Statistical
1
2004
89
0.050
Why?
Eligibility Determination
1
2004
22
0.050
Why?
Urban Population
1
2005
161
0.050
Why?
Health Surveys
2
2018
238
0.050
Why?
Prescription Fees
1
2004
14
0.050
Why?
Length of Stay
1
2007
673
0.050
Why?
Algorithms
1
2007
673
0.050
Why?
Laparoscopy
1
2025
180
0.050
Why?
Data Interpretation, Statistical
3
2009
166
0.050
Why?
MEDLINE
1
2002
8
0.050
Why?
Prospective Studies
1
2008
2433
0.050
Why?
Antidepressive Agents, Second-Generation
1
2002
28
0.050
Why?
Neuropsychological Tests
1
2003
346
0.050
Why?
Analgesics
1
2023
106
0.050
Why?
Quality of Life
2
2023
893
0.050
Why?
Cognition Disorders
1
2003
213
0.050
Why?
Pharmacy
2
2018
54
0.040
Why?
Gastrointestinal Hemorrhage
1
2022
91
0.040
Why?
Patient Protection and Affordable Care Act
1
2020
50
0.040
Why?
Needs Assessment
1
2020
141
0.040
Why?
Ohio
1
2019
46
0.040
Why?
Myocardial Revascularization
1
2019
29
0.040
Why?
Quality of Health Care
1
2020
186
0.040
Why?
Pharmacoepidemiology
1
2017
7
0.030
Why?
Universities
1
2018
174
0.030
Why?
Research Design
2
2014
368
0.030
Why?
Vaccination
1
2019
294
0.030
Why?
Pilot Projects
1
2019
725
0.030
Why?
Communication
1
2018
255
0.030
Why?
Qualitative Research
1
2018
365
0.030
Why?
Electronic Health Records
1
2018
274
0.030
Why?
Attitude of Health Personnel
1
2018
358
0.030
Why?
Survival Analysis
1
2014
656
0.020
Why?
Ischemic Attack, Transient
1
2013
60
0.020
Why?
Lipids
1
2013
163
0.020
Why?
Linear Models
1
2013
288
0.020
Why?
Diagnosis, Dual (Psychiatry)
1
2012
40
0.020
Why?
Stress Disorders, Post-Traumatic
1
2017
393
0.020
Why?
Diagnostic Tests, Routine
1
2012
31
0.020
Why?
Cost Control
1
2011
13
0.020
Why?
Blood Pressure
1
2013
525
0.020
Why?
Acute Coronary Syndrome
1
2012
106
0.020
Why?
Reproducibility of Results
2
2005
1223
0.020
Why?
Dibenzothiazepines
1
2010
10
0.020
Why?
Adolescent Behavior
1
2011
107
0.020
Why?
Hypnotics and Sedatives
1
2010
73
0.020
Why?
Off-Label Use
1
2010
24
0.020
Why?
Observation
1
2009
8
0.020
Why?
Epidemiologic Methods
1
2009
47
0.020
Why?
Causality
1
2009
51
0.020
Why?
Diabetes Mellitus
1
2013
318
0.020
Why?
Mood Disorders
1
2009
60
0.020
Why?
Quinolones
1
2010
54
0.020
Why?
Anxiety Disorders
1
2009
128
0.020
Why?
Piperazines
1
2010
125
0.020
Why?
ROC Curve
1
2009
249
0.020
Why?
Headache
1
2008
74
0.020
Why?
Sex Factors
1
2009
735
0.020
Why?
Confidence Intervals
1
2007
158
0.020
Why?
Probability
1
2007
171
0.020
Why?
Drug Utilization Review
1
2005
22
0.010
Why?
Bone Density
1
2007
396
0.010
Why?
Drug Monitoring
1
2005
81
0.010
Why?
Registries
1
2007
638
0.010
Why?
Health Maintenance Organizations
1
2002
16
0.010
Why?
Antidepressive Agents, Tricyclic
1
2002
28
0.010
Why?
Costs and Cost Analysis
1
2002
94
0.010
Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description